PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

2014-01-24
(Press-News.org) Contact information: Sophia Haque
sophia.haque@rhul.ac.uk
01-784-443-552
Royal Holloway, University of London
Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

Scientists have discovered the use of a simple single-celled amoeba to understand the function of human proteins in causing Alzheimer's disease.

The new study, published in the Journal of Cell Science today (Friday 24 January) by researchers at Royal Holloway, University of London and the Institute of Psychiatry King's College London, reveals how the amoeba will enable a better understanding of the function of these Alzheimer's disease-associated proteins in the cell without the need for testing on animals, with the ultimate aim of developing improved treatments for the degenerative disease.

Mutations in presenilin proteins cause inherited forms of Alzheimer's disease, and these proteins also play a major role in the age-related onset of the condition.

However, understanding the role of these proteins is difficult, since cells lacking the proteins are non-viable.

Presenilin proteins have been extensively analysed and animals are commonly used in this research area, but these experiments are problematic since deletion of the proteins in animal cells causes a loss of viability and blocks the development.

"This discovery allows us to examine the role for the human presenilin 1 protein, without the use of animal testing. It is amazing that so simple an organism lends itself to the study of such a complex disease," says Professor Robin Williams from the School of Biological Sciences at Royal Holloway.

"This work on the amoeba Dictyostelium shows we can successfully use this simple model to try to better understand the normal roles of other proteins and genes involved in Alzheimer's disease and other forms of neurodegeneration," added Dr Richard Killick from the Institute of Psychiatry King's College London.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Central Europeans already digested milk as well as us 1,000 years ago

2014-01-24
Back in the Middle Ages, Central Europeans were already capable of digesting milk, yoghurt and cheese just as well as us today. Researchers at the University of Zurich's Centre for ...

Generation blame: How age affects our views of anti-social behavior

2014-01-24
A study of interpretations of anti-social behaviour (ASB) found a significant gap between the views of different age groups - with older people more likely than younger people to interpret ...

Changing climate: How dust changed the face of the earth

2014-01-24
Bremerhaven/Germany, 24 January 2014. In spring 2010, ...

World's first magma-enhanced geothermal system created in Iceland

2014-01-24
RIVERSIDE, Calif. — In 2009, a borehole drilled at Krafla, ...

Using engineering plus evolutionary analyses to answer natural selection questions

2014-01-24
AMHERST, Mass. – Introducing a new approach that combines evolutionary and engineering analyses to identify the targets of natural selection, researchers ...

Various microstructures fabricated by a solvent-cast 3-D printing technique

2014-01-24
Various microstructures including straight filaments, layer-by-layer ...

Researchers discover potential drug targets for early onset glaucoma

2014-01-24
Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that ...

National plan for preventing healthcare-associated infections shows progress

2014-01-24
Philadelphia, Pa. (January 23, 2014) – Independent evaluators have found that measurable ...

The lung microbiome: A new frontier in pulmonary medicine

2014-01-24
The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine." ...

Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers

2014-01-24
NEW YORK, NY (January 23, 2014) — Survivors of breast cancer have a one in ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Researchers discover simple amoeba holds the key to better treatment for Alzheimer's